New approaches in the medical management of venous ulceration
- PMID: 8434807
- DOI: 10.1177/000331979304400208
New approaches in the medical management of venous ulceration
Abstract
This literature survey of the medical treatment of venous ulcers of the lower extremities discusses five classes of agents: (1) fibrinolytics, (2) hydroxyrutosides, (3) prostaglandins, (4) methylxanthines, and (5) others. The authors conclude that all these agents require further research.
Similar articles
-
Pharmacological treatments for venous leg ulcers.J Wound Care. 1999 Apr;8(4):195-7. doi: 10.12968/jowc.1999.8.4.25858. J Wound Care. 1999. PMID: 10455635 Review. No abstract available.
-
Liver enzymes and lipid levels in patients with lipodermatosclerosis and venous ulcers treated with a prototypic anabolic steroid (stanozolol): a prospective, randomized, double-blinded, placebo-controlled trial.Int J Low Extrem Wounds. 2015 Mar;14(1):11-8. doi: 10.1177/1534734614562276. Epub 2015 Feb 3. Int J Low Extrem Wounds. 2015. PMID: 25652757 Clinical Trial.
-
Management of venous ulcers.Am Fam Physician. 1986 Feb;33(2):274-81. Am Fam Physician. 1986. PMID: 2936224 No abstract available.
-
[Comparison of combined treatment for venous ulcers in postphlebitic syndrome and use of PGE-1--introductory remarks].Wiad Lek. 1997;50 Suppl 1 Pt 2:65-8. Wiad Lek. 1997. PMID: 9424929 Clinical Trial. Polish.
-
Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon.Angiology. 2000 Mar;51(3):197-205. doi: 10.1177/000331970005100303. Angiology. 2000. PMID: 10744007 Review.
Cited by
-
Optimal treatment of venous (stasis) ulcers in elderly patients.Drugs Aging. 1994 Nov;5(5):323-34. doi: 10.2165/00002512-199405050-00002. Drugs Aging. 1994. PMID: 7833586 Review.
-
Some observations on the effect of Daflon (micronized purified flavonoid fraction of Rutaceae aurantiae) in bancroftian filarial lymphoedema.Filaria J. 2003 Mar 12;2(1):5. doi: 10.1186/1475-2883-2-5. Filaria J. 2003. PMID: 12691606 Free PMC article.
-
Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders.Drugs Aging. 1995 Dec;7(6):480-503. doi: 10.2165/00002512-199507060-00007. Drugs Aging. 1995. PMID: 8601054 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources